Addictions, Drug & Alcohol Institute

Mary Hatch PhD

Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention.  Her work has focused on the intersection of substance use and HIV-related sex and drug use risk behaviors from both the individual and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist. She practiced in the community for 17 years and is now at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.

Dr. Hatch is the Co-Director of the Pacific Northwest Node of the NIDA Clinical Trials Network. She is also the Director of the Clinical Trials Consultation and Technical Assistance Program (C-TAP).

Titles

Associate Professor, Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, UW School of Medicine
Multiple PI, Pacific NW Node of the NIDA Clinical Trials Network
Director, Clinical Trials Consultation & Technical Assistance Program

Education

BA, Amherst College
PhD, Clinical Psychology, University of Nebraska-Lincoln
Postdoctoral fellowship at the VA Puget Sound Health Care System’s Center for Excellence in Substance Abuse Treatment and Evaluation (CESATE)

Linked Information

Publications

Research

Recent Publications

  1. Gordon AJ, Hatch MA, Kropp FB, Liebschutz JM, Mooney LJ, Cochran G. Twenty-five years of the NIDA clinical trials network and the future of addiction research. Journal of Substance Use & Addiction Research 2026: 210140 (in press). [doi: 10.1016/j.josat.2026.210140] PMID: 42893770
  2. Paschen-Wolff MM, Tross S, Nelson CM, Hatch MA, Meche D, Ertl MM, Wright L, Laschober TC. Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the Southern United States. AIDS Care 2025;37(1):21-32. [doi: 10.1080/09540121.2024.2438923] PMID: 39651544
  3. Tross S, Laschober TC, Paschen-Wolff M, Ertl M, Nelson CM, Wright L, Lancaster C, Feaster DJ, Monger M, Toal P, Fegley JP, Meche D, Hankey C, Woodhouse C, Spector A, Dresser L, Moran L, Jelstrom E, Haynes L, Shoptaw S, Hatch MA. Willingness to use oral and long-acting injectable PrEP in substance-using men who have sex with men (SU-MSM) in high HIV incidence Southern U.S. cities: A NIDA Clinical Trials Network study. AIDS and Behavior 2025;29(4):1192-1204. [doi: 10.1007/s10461-024-04594-7]
  4. Le MH, Laschober TC, Tross S, Paschen-Wolff M, Ertl MM, Wright L, Hatch MA. Attitudes toward and experience with naloxone among people who use drugs in the Southeastern United States. International Journal of Drug Policy 2025;139:10479. [doi: 10.1016/j.drugpo.2025.104769] PMID: 40073718
  5. Ertl MM, Woodhouse C, Meche D, Forrest DW, Fegley J, Paschen-Wolff M, Laschober TC, Hatch MA, Nelson CM, Wright L, Tross S. Using structural modeling to examine barriers and facilitators of HIV pre-exposure prophylaxis willingness and length of use in men who have sex with men who use substances in eight Southern U.S. cities. AIDS Patient Care and STDS 2025;39(6):245-256. [doi: 10.1089/apc.2025.0036] PMID: 40401366 PMCID: PMC12172640

View all 52 publications by Mary Hatch

Research Interests

  • (Research) Substance use disorder treatment; intersection of substance use and HIV risk; Gender; implementation science.
  • (Clinical) Addiction treatment; Comorbidity of depression, anxiety, PTSD and addiction in adults.

Activities

Research & Other Projects